Also found in: Dictionary.
EYETEast York/East Toronto (Canada)
References in periodicals archive ?
Furthermore, the short interest reduced by more than six percent last month, so short sellers are actually drifting away from EYET.
EYET rallied 14 percent on October 14 when competitor Alcon (ACL) announced the results of a Phase III trial of its treatment for AMD.
Founded in 2000, and recently listed on NASDAQ as EYET, the New York City-based company is focused on meeting the unmet medical needs of patients with conditions that affect the back of the eye.
33 15% 11% Q1 2004 Biotech IPOs Share Share % Change Issue Price Price % Change since Price 3/31/03 6/30/04 Q2 IPO Company Ticker ($USD) ($USD) ($USD) 2004 (6/30/04) Eyetech Pharma EYET $21.